Transcatheter liver-directed intraarterial therapy represents an important therapeutic approach in individuals with liver-dominant neoplasms. Transarterial chemoembolization and embolization—the archetypical transarterial embolotherapies in interventional oncology locoregional therapy (LRT)—have gained acceptance and application during the past 4 decades for treatment of various primary hepatic malignancies and secondary cancers and are widely employed in current interventional radiology (IR) practice.
Ron C. Gaba, MD, R. Peter Lokken, MD, MPH, Ryan M. Hickey, MD, Andrew J. Lipnik, MD, Robert J. Lewandowski, MD, Riad Salem, MD, MBA, Daniel B. Brown, MD, T. Gregory Walker, MD, James E. Silberzweig, MD, Mark Otto Baerlocher, MD, Ana Maria Echenique, MD, Mehran Midia, MD, Jason W. Mitchell, MD, MPH, MBA, Siddharth A. Padia, MD, Suvranu Ganguli, MD, Thomas J. Ward, MD, Jeffrey L. Weinstein, MD, Boris Nikolic, MD, MBA, and Sean R. Dariushnia, MD, for the Society of Interventional Radiology Standards of Practice Committee